Sequent Scientific sells stake in Strides Pharma, acquires 40% in Provet
Post the acquisition of minority stake, which is expected to close on or before October 31, 2020, Provet will become a wholly owned subsidiary of the company, says Manish Gupta, MD, Sequent Scientific.
Other News Videos
SEBI unveils Pilot DLT tokenisation project as risk evaluation process continues
Up to Rs 25 petrol, diesel hike? Oil firms still bleeding Rs 1,380 crore daily
Trendline Breakout Points to Bullish Reversal in Deepak Nitrite
Reliance Industries Q4 Results: Profit falls 13% YoY as energy margins weaken; Jio and retail shine
LIVE | Wipro Q4 results: Profit drops 1.89% on yearly basis | Earnings under pressure